According to The Insight Partners, the Image Guided Radiotherapy Market size is projected to surge from US$ 1,814.25 million in 2022 to US$ 5,650.72 million by 2030, with the market estimated to grow at a CAGR of 15.3% during 2022–2030. The rapid expansion reflects increasing cancer burden, technological advances in radiation therapy, growing awareness of precision treatment, and improvements in healthcare infrastructure. IGRT uses periodic two- and three-dimensional imaging during radiation treatment to align therapy with the actual position of the target, helping clinicians deliver radiation more precisely and reduce exposure to normal tissues. The report also identifies AI and ML integration as an important opportunity, while emerging healthcare markets and innovative radiation therapy techniques are expected to further influence market dynamics.
Download Sample PDF – https://www.theinsightpartners.com/sample/TIPRE00009118
Image Guided Radiotherapy Market Size, Share, Trends, Analysis, and Forecast by 2030
- Market Size: The global market was valued at US$ 1,814.25 million in 2022 and is projected to reach US$ 5,650.72 million by 2030.
- Market Growth: The market is expected to expand at a 15.3% CAGR from 2022 to 2030, demonstrating strong demand for advanced radiation treatment technologies.
- Regional Share: North America held a dominant position, valued at US$ 760.70 million in 2022, and is projected to reach US$ 2,409.12 million by 2030.
- Key Trend: Increasing integration of AI and ML with image-guided radiation therapy is improving treatment planning, tumor localization, and personalization.
- Technology Trend: MRI, CT, PET, and other imaging technologies are becoming increasingly important in real-time treatment guidance.
- Application Trend: Breast cancer held the largest application share in 2022, while lung cancer is projected to record the highest CAGR of 16.3% during 2022–2030.
- Imaging Trend: MRI held the largest share by imaging type in 2022, whereas CT imaging is expected to register the highest CAGR of 15.8%.
- End-User Trend: Hospitals represented the largest end-user segment in 2022, while oncology centers are projected to achieve the highest CAGR of 16.0%.
- 2034 Outlook: Beyond the published 2030 forecast, continued cancer incidence, precision oncology, AI-enabled treatment planning, and adoption of advanced imaging are expected to support sustained industry expansion toward 2030.
Market Drivers
The rising prevalence of cancer worldwide is one of the primary factors supporting demand for image-guided radiotherapy. Radiation therapy is an important component of cancer management, and IGRT enables treatment teams to better locate tumors and direct radiation beams with greater precision. This capability can help reduce radiation exposure to healthy tissue and minimize treatment-related side effects. The increasing focus on personalized cancer care is also encouraging healthcare providers to adopt technologies capable of adapting treatment to individual patient anatomy and tumor characteristics.
Technological innovation is another major growth factor. Integration of advanced imaging modalities with radiation delivery systems is improving treatment accuracy, while AI and ML are opening opportunities for automated image interpretation, treatment planning, and workflow optimization. These developments are particularly relevant for complex tumors that require accurate positioning and repeated imaging during therapy.
Market Segmentation Analysis
The Image Guided Radiotherapy Market is segmented by type, application, imaging type, end user, and geography. By type, the market comprises products and services, with products holding the largest share in 2022. The services segment is expected to record a CAGR of 15.5% during 2022–2030. By application, segments include breast cancer, lung cancer, gastrointestinal cancer, prostate cancer, gynecological cancers, head and neck cancer, and others. Breast cancer accounted for the largest share in 2022.
By imaging type, the market includes MRI, PET, CT imaging, and others. MRI held the largest share in 2022, while CT imaging is expected to experience the fastest growth. By end user, the market is categorized into hospitals, oncology centers, and radiotherapy centers. Hospitals held the largest share in 2022, while oncology centers are expected to demonstrate strong growth during the forecast period.
Regional Analysis
North America: North America dominates the Image Guided Radiotherapy Market, supported by advanced healthcare infrastructure, high cancer incidence, favorable reimbursement environments, and rapid adoption of sophisticated treatment technologies. The region is expected to remain a major contributor to global industry growth through the forecast period.
Europe: Europe is expected to experience substantial growth due to advanced treatment facilities, skilled healthcare professionals, government support, and investments in cancer research and development.
Asia-Pacific: Asia-Pacific is identified as the fastest-growing regional market, supported by increasing cancer prevalence, greater cancer awareness, improving healthcare infrastructure, and increasing availability of advanced treatment technologies.
South and Central America: Improvements in healthcare infrastructure and growing awareness of modern cancer treatment solutions are expected to create new opportunities.
Middle East and Africa: Increasing investments in healthcare infrastructure and improving access to advanced oncology services are expected to support long-term adoption.
Top Players in the Image Guided Radiotherapy Market
Key players analyzed by The Insight Partners include:
- ViewRay
- GE Healthcare
- Hitachi, Ltd.
- Siemens AG
- Koninklijke Philips N.V.
- TOSHIBA CORPORATION
- Varian Medical Systems, Inc.
- Vision RT Ltd.
- Elekta AB
- Accuray Incorporated
- HORIBA Group
These companies are pursuing product development, technological innovation, strategic collaborations, mergers, acquisitions, and portfolio expansion to strengthen their positions in the competitive landscape. Recent developments highlighted by The Insight Partners include Philips’ expansion of its mobile C-arm portfolio, GE HealthCare’s expansion of MRI contrast-agent offerings and PET/MR capabilities, and regulatory approval for ViewRay’s MRIdian MRI-guided radiation therapy system in China.
Get Premium Research Report Market Size and Report at:
https://www.theinsightpartners.com/buy/TIPRE00009118
Market Trends and Growth Analysis
The transition toward precision oncology is expected to remain a central trend. Healthcare providers are seeking radiation therapy solutions that can deliver highly targeted treatment while reducing damage to healthy tissues. The integration of real-time imaging, automation, AI, and ML is therefore expected to reshape treatment planning and delivery. Increasing adoption of minimally invasive treatment approaches and growing investments in oncology centers are also likely to support demand for IGRT systems.
About Us
The Insight Partners is an one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us
Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish
